Search Results - "HOPP; MICHAEL" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension

Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension

by Trenkwalder, Claudia, Prof, Beneš, Heike, MD, Grote, Ludger, MD, García-Borreguero, Diego, MD, Högl, Birgit, MD, Hopp, Michael, MD, Bosse, Björn, Dipl Stat, Oksche, Alexander, MD, Reimer, Karen, Prof, Winkelmann, Juliane, Prof, Allen, Richard P, PhD, Kohnen, Ralf, PhD
Published in Lancet neurology (01.12.2013)

Get full text

Journal Article

Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial

Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial

by Trenkwalder, Claudia, Prof, Chaudhuri, K Ray, Prof, Martinez-Martin, Pablo, MD, Rascol, Olivier, Prof, Ehret, Reinhard, MD, Vališ, Martin, PhD, Sátori, Maria, MD, Krygowska-Wajs, Anna, Prof, Marti, Maria J, Prof, Reimer, Karen, Prof, Oksche, Alexander, MD, Lomax, Mark, MSc, DeCesare, Julia, MSc, Hopp, Michael, MD
Published in Lancet neurology (01.12.2015)

Get full text

Journal Article

Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management

Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management

by Holzer, Peter, Ahmedzai, Sam H, Niederle, Norbert, Leyendecker, Petra, Hopp, Michael, Bosse, Björn, Spohr, Ingrid, Reimer, Karen
Published in Journal of opioid management (29.01.2018)

Get more information

Journal Article

Refocusing of Attention on Positive Events Using Monitoring-Based Feedback and Microinterventions for Patients With Chronic Musculoskeletal Pain in the PerPAIN Randomized Controlled Trial: Protocol for a Microrandomized Trial

Refocusing of Attention on Positive Events Using Monitoring-Based Feedback and Microinterventions for Patients With Chronic Musculoskeletal Pain in the PerPAIN Randomized Controlled Trial: Protocol for a Microrandomized Trial

by Ader, Leonie, Schick, Anita, Löffler, Martin, Löffler, Annette, Beiner, Eva, Eich, Wolfgang, Vock, Stephanie, Sirazitdinov, Andrei, Malone, Christopher, Hesser, Jürgen, Hopp, Michael, Ruckes, Christian, Flor, Herta, Tesarz, Jonas, Reininghaus, Ulrich
Published in JMIR research protocols (20.09.2023)

Get full text

Journal Article

Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers

Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers

by Smith, Kevin, PhD, Hopp, Michael, MD, Mundin, Gill, BSc, Leyendecker, Petra, MSc, Bailey, Paul, BSc, Grothe, Birgit, Dipl.-Biol, Uhl, Reiner, BSc, Reimer, Karen, MD, PhD
Published in Clinical therapeutics (01.11.2008)

Get full text

Journal Article

Fibroblast growth on surface-modified dental implants: An in vitro study

Fibroblast growth on surface-modified dental implants: An in vitro study

by Groessner-Schreiber, Birte, Neubert, Anja, Müller, Wolf-Dieter, Hopp, Michael, Griepentrog, Michael, Lange, Klaus-Peter
Published in Journal of biomedical materials research. Part A (15.03.2003)

Get full text

Journal Article

Hair for brain trade-off, a metabolic bypass for encephalization

Hair for brain trade-off, a metabolic bypass for encephalization

by Dror, Yosef, Hopp, Michael
Published in SpringerPlus (27.09.2014)

Get full text

Journal Article

Low absolute bioavailability of oral naloxone in healthy subjects

Low absolute bioavailability of oral naloxone in healthy subjects

by Smith, Kevin, Hopp, Michael, Mundin, Gill, Bond, Simon, Bailey, Paul, Woodward, Jo, Bell, David
Published in International journal of clinical pharmacology and therapeutics (01.05.2012)

Get more information

Journal Article

A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain

A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain

by Ahmedzai, Sam H, Nauck, Friedemann, Bar-Sela, Gil, Bosse, Björn, Leyendecker, Petra, Hopp, Michael
Published in Palliative medicine (01.01.2012)

Get full text

Journal Article

A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation

A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation

by Meissner, Winfried, Leyendecker, Petra, Mueller-Lissner, Stefan, Nadstawek, Joachim, Hopp, Michael, Ruckes, Christian, Wirz, Stefan, Fleischer, Wolfgang, Reimer, Karen
Published in European journal of pain (01.01.2009)

Get more information

Journal Article

Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain

Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain

by Ahmedzai, Sam H., Leppert, Wojciech, Janecki, Marcin, Pakosz, Artur, Lomax, Mark, Duerr, Heike, Hopp, Michael
Published in Supportive care in cancer (01.03.2015)

Get full text

Journal Article

Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study

Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study

by Cutolo, Maurizio, Hopp, Michael, Liebscher, Stefan, Dasgupta, Bhaskar, Buttgereit, Frank
Published in Rheumatic & musculoskeletal diseases open (01.01.2017)

Get full text

Journal Article

Analgesic Efficacy and Safety of Oxycodone in Combination With Naloxone as Prolonged Release Tablets in Patients With Moderate to Severe Chronic Pain

Analgesic Efficacy and Safety of Oxycodone in Combination With Naloxone as Prolonged Release Tablets in Patients With Moderate to Severe Chronic Pain

by Vondrackova, Dana, Leyendecker, Petra, Meissner, Winfried, Hopp, Michael, Szombati, Istvan, Hermanns, Kai, Ruckes, Christian, Weber, Susanne, Grothe, Birgit, Fleischer, Wolfgang, Reimer, Karen
Published in The journal of pain (01.12.2008)

Get full text

Journal Article

Prolonged-Release (PR) Oxycodone/Naloxone Improves Bowel Function Compared with Oxycodone PR and Provides Effective Analgesia in Chinese Patients with Non-malignant Pain: A Randomized, Double-Blind Trial

Prolonged-Release (PR) Oxycodone/Naloxone Improves Bowel Function Compared with Oxycodone PR and Provides Effective Analgesia in Chinese Patients with Non-malignant Pain: A Randomized, Double-Blind Trial

by Leng, Xiaomei, Zhang, Fengxiao, Yao, Shanglong, Weng, Xisheng, Lu, Kaizhi, Chen, Gouzhong, Huang, Ming, Huang, Yuguang, Zeng, Xiaofeng, Hopp, Michael, Lu, Guodong
Published in Advances in therapy (01.03.2020)

Get full text

Journal Article

A COMBINATION OF AN OPIOID AGONIST AND AN OPIOID ANTAGONIST IN THE TREATMENT OF PARKINSON'S DISEASE

A COMBINATION OF AN OPIOID AGONIST AND AN OPIOID ANTAGONIST IN THE TREATMENT OF PARKINSON'S DISEASE

by HOPP MICHAEL, TRENKWALDER CLAUDIA
Year of Publication 06.07.2015

Get full text

Patent

PANDA: Prolonged release oxycodone/naloxone (OXN PR) for severe Parkinson’s disease (PD)-related pain

PANDA: Prolonged release oxycodone/naloxone (OXN PR) for severe Parkinson’s disease (PD)-related pain

by Chaudhuri, K. Ray, Martinez-Martin, Pablo, Rascol, Olivier, Lomax, Mark, DeCesare, Julia, Hopp, Michael
Published in Parkinsonism & related disorders (01.01.2016)

Get full text

Journal Article

PANDA: Prolonged release oxycodone/naloxone (OXN PR) for severe Parkinson’s disease (PD)-related pain

PANDA: Prolonged release oxycodone/naloxone (OXN PR) for severe Parkinson’s disease (PD)-related pain

by Chaudhuri, K. Ray, Martinez-Martin, Pablo, Rascol, Olivier, Lomax, Mark, DeCesare, Julia, Hopp, Michael
Published in Parkinsonism & related disorders (01.01.2016)

Get full text

Journal Article

A COMBINATION OF AN OPIOID AGONIST AND AN OPIOID ANTAGONIST IN THE TREATMENT OF PARKINSON'S DISEASE

A COMBINATION OF AN OPIOID AGONIST AND AN OPIOID ANTAGONIST IN THE TREATMENT OF PARKINSON'S DISEASE

by HOPP MICHAEL, TRENKWALDER CLAUDIA
Year of Publication 27.09.2013

Get full text

Patent

USE OF OPIOID ANTAGONISTS FOR TREATING URINARY RETENTION

USE OF OPIOID ANTAGONISTS FOR TREATING URINARY RETENTION

by HOPP MICHAEL, LEYENDECKER PETRA
Year of Publication 26.09.2013

Get full text

Patent

Efficacy of Conventional and Liposomal Povidone–Iodine in Infected Mesh Skin Grafts: An Exploratory Study

Efficacy of Conventional and Liposomal Povidone–Iodine in Infected Mesh Skin Grafts: An Exploratory Study

by Vogt, Peter M., Hauser, Joerg, Mueller, Stefan, Bosse, Bjoern, Hopp, Michael
Published in Infectious diseases and therapy (01.12.2017)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[11]